Copyright
©2012 Baishideng Publishing Group Co.
World J Hepatol. Apr 27, 2012; 4(4): 154-157
Published online Apr 27, 2012. doi: 10.4254/wjh.v4.i4.154
Published online Apr 27, 2012. doi: 10.4254/wjh.v4.i4.154
Figure 1 Two months earlier, our patient had normal serum alanine aminotransferase, alkaline phosphatase and total bilirubin (baseline).
The peak total bilirubin level lagged 19 d behind the peak ALT and ALP levels. There was striking improvement in serum aminotransferase and total bilirubin levels after initiation of prednisone (50 mg/d). Laboratory values remained normal after prednisone therapy was discontinued. ALT: Alanine aminotransferase; ALP: Alkaline phosphatase.
Figure 2 Portal tract and lobules with marked mixed inflammation and parenchymal loss (hematoxylin and eosin staining, X100).
Figure 3 Minute alpha-1 antitrypsin positive globules in periportal hepatocytes; diffuse background staining for alpha-1 antitrypsin is also presented (alpha-1 antitrypsin stain, X200).
- Citation: Weinstein DH, Twaddell WS, Raufman JP, Philosophe B, Mindikoglu AL. SlimQuick™ - associated hepatotoxicity in a woman with alpha-1 antitrypsin heterozygosity. World J Hepatol 2012; 4(4): 154-157
- URL: https://www.wjgnet.com/1948-5182/full/v4/i4/154.htm
- DOI: https://dx.doi.org/10.4254/wjh.v4.i4.154